908 Devices (MASS) Depreciation and Depletion (2024 - 2025)

908 Devices' (MASS) quarterly Depreciation and Depletion came in at $400000.0 in Q4 2025, up 100.0% year-on-year from $200000.0 in Q4 2024, and little changed on a QoQ basis from $400000.0 in Q3 2025.

908 Devices (MASS) Depreciation and Depletion (2024 - 2025) Analysis & Trends

908 Devices (MASS) has 2 years of Depreciation and Depletion data on file, last reported at $400000.0 in Q4 2025.

  • On a quarterly basis, Depreciation and Depletion rose 100.0% year-over-year to $400000.0 in Q4 2025; TTM through Dec 2025 was $1.3 million, a N/A change from a year earlier, with the FY2025 full-year figure at $1.3 million, up 30.0% from the prior year.
  • Depreciation and Depletion for Q4 2025 stood at $400000.0, roughly flat from $400000.0 in the prior quarter.
  • Over the last five years, Depreciation and Depletion for MASS reached as high as $400000.0 in Q3 2025 and fell as low as $200000.0 in Q4 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 381.00 Mn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 120.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 308.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 89.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 78.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 908 Devices 261.78 Mn 150.04 Mn 6.88 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 400,000.00
Dec 31, 2025 400,000.00
Sep 30, 2025 400,000.00
Sep 30, 2025 400,000.00
Dec 31, 2024 200,000.00
Dec 31, 2024 200,000.00
Sep 30, 2024 300,000.00
Sep 30, 2024 300,000.00